key: cord-0806349-z5d0qh87
authors: Su, Xiaowei W.; Palka, Sydney V.; Rao, Rahul R.; Chen, Fred S.; Brackney, Christopher R.; Cambi, Franca
title: SARS‐CoV‐2–associated Guillain‐Barré syndrome with dysautonomia
date: 2020-06-01
journal: Muscle Nerve
DOI: 10.1002/mus.26988
sha: ae7c5faf80045a7fc301433d3407a7c9a9b452aa
doc_id: 806349
cord_uid: z5d0qh87

nan

Wuhan, China, showed that those with central nervous system symptoms had lower lymphocyte and platelet counts and higher BUN levels compared with those with peripheral nervous system or no neurological symptoms. 9 Although these laboratory values in the patient we described are similar to those seen in the Wuhan cohort with peripheral nervous system or no neurologic complications, the underlying pathophysiology predisposing certain COVID-19 patients to 

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Guillain-Barré syndrome associated with SARS-CoV-2

Guillain-Barré syndrome related to COVID-19 infection

Guillain Barré syndrome associated with COVID-19 infection: a case report

Guillain-Barré syndrome associated with SARS-CoV-2 infection

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. (to be published)

Guillain-Barré syndrome as a Complication of SARS-CoV-2 Infection

Guillain-Barré syndrome associated with SARS-CoV-2 infection

Neurologic manifestations of hospitalized patients with coronavirus disease